Drug Discovery & Development Related Content

Scott E. Lukas received his PhD in pharmacology and toxicology in 1979 from the University of Maryland. After a post-doctoral fellowship at Johns Hopkins University, he joined NIDA Addiction Research Center for 18 months before moving to McLean in 1984. Promoted to professor in 2003, Dr. Lukas...

Stephen J. Kohut, PhD, focuses his research primarily on two main interacting lines of investigation: understanding how alterations in underlying neurobiology alter behavioral responses to drugs, especially stimulants and opioids, and medications discovery for drug misuse and addiction. Dr. Kohut’s...

Rajeev I. Desai, PhD, is an assistant professor of psychiatry at Harvard Medical School and director of the Integrative Neurochemistry Laboratory at McLean Hospital. Dr. Desai received his PhD in psychology/behavioral pharmacology at the University of Birmingham, U.K. He completed post-doctoral...

Carol A. Paronis, PhD, is director of the Laboratory of Preclinical Pharmacology at McLean Hospital and an associate professor of psychiatry at Harvard Medical School. Dr. Paronis received her PhD in pharmacology from Emory University and completed post-doctoral fellowships in pharmacology at the...

Frank Tarazi, MBBS, PhD, MBA is an associate professor of Psychiatry at Harvard Medical School, and director of the Laboratory in Pharmacoeconomics and Health Outcomes at McLean Hospital. He is a preclinical and clinical expert on Alzheimer’s disease, Parkinson’s disease, schizophrenia, depression...

As director of the Laboratory for Computational Neuroscience, Dr. Siekmeier’s research centers on the computational modeling of the hippocampus, an area of brain thought to be responsible for encoding memories, and one that has been implicated in the etiology of schizophrenia. The goals of this...